Thursday, 6 August 2026

Indian corporate news, decoded into deal flow

NSE LIVE
NIFTY 50 INDIA VIX
as of
MARKETS
DEAL FLOW
NRB Industrial Bearings Acquires 9.08% Stake… ▲ Mergers & Acquisitions TVS Group Announces Major NBFC Restructuring:… ▲ Mergers & Acquisitions Viviana Power Tech Q1 FY27 Results:… ▲ Order Book UPL Q1 FY27 Results: Profit Returns… ▲ Capex & Future Plan Nucleus Software Launches FinnOne Neo 9.0… ▲ Capex & Future Plan Clean Science and Technology Posts Record… ▲ Results DCM Shriram International Promoter Acquires 30.07… ▲ Shareholding & Insider Moves
Home / Capex & Future Plans / Sai Life Sciences Expands R&D Capabilities with New Hyderabad Facility
CX · Capex & Future Plans

Sai Life Sciences Expands R&D Capabilities with New Hyderabad Facility

Sai Life Sciences Expands R&D Capabilities with New Hyderabad Facility

Sai Life Sciences to Expand R&D Capabilities with New Facility in Hyderabad

Sai Life Sciences Limited has announced plans to enhance its R&D capabilities by establishing a new research and development facility in Shamirpet, Hyderabad.

Key Highlights of the Expansion

  • Location: The new facility will be situated in Shamirpet, Hyderabad, augmenting the existing Unit II Hyderabad facility.
  • Land Lease: The company has secured 1.21 acres of land, including existing building structures, through a long-term lease agreement.
  • Purpose: The facility aims to bolster the company’s R&D infrastructure, supporting future growth.
  • Investment: The project requires an initial investment of Rs. 15 crore, funded entirely through internal accruals.
  • Timeline: Partial operations are projected to commence in Q4 of FY 2025-26.

This expansion underscores Sai Life Sciences’ commitment to strengthening its research capabilities, paving the way for innovation and long-term growth.